4S期神经母细胞瘤：其独特之处何在？ - Suppr

Suppr

超能文献

Stage 4S neuroblastoma: what makes it special?

作者信息

Matthay K K

出版信息

J Clin Oncol. 1998 Jun;16(6):2003-6. doi: 10.1200/JCO.1998.16.6.2003.

DOI:10.1200/JCO.1998.16.6.2003

PMID:9626196

Abstract

摘要

相似文献

Stage 4S neuroblastoma: what makes it special?4S期神经母细胞瘤：其独特之处何在？

J Clin Oncol. 1998 Jun;16(6):2003-6. doi: 10.1200/JCO.1998.16.6.2003.

High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma.高亲和力神经生长因子受体表达（gp140trkA）、N-myc扩增、组织病理学与神经母细胞瘤患者的生存情况

Prog Clin Biol Res. 1994;385:163-8.

NGF induces terminal differentiation in trkA expressing neuroblastoma cells in vitro and in vivo.神经生长因子（NGF）在体外和体内均可诱导表达trkA的神经母细胞瘤细胞发生终末分化。

Prog Clin Biol Res. 1994;385:177-83.

Clinical significance of expression of neurotrophic factors and their receptors in neuroblastoma.神经营养因子及其受体在神经母细胞瘤中的表达的临床意义

Prog Clin Biol Res. 1994;385:155-61.

Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.神经营母细胞瘤中TRKA表达的临床相关性：与N-MYC扩增及CD44表达的比较

Br J Cancer. 1997;75(8):1151-5. doi: 10.1038/bjc.1997.198.

Retinoic acid induced differentiation is mediated by trkB receptors.视黄酸诱导的分化由TrkB受体介导。

Prog Clin Biol Res. 1994;385:185-98.

Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.全长神经营养因子受体trk-C和trk-A的mRNA在预后良好的神经母细胞瘤中的共表达。

Eur J Cancer. 1997 Oct;33(12):2058-63. doi: 10.1016/s0959-8049(97)00290-6.

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.侵袭性神经母细胞瘤中缺乏高亲和力神经生长因子受体。

J Natl Cancer Inst. 1993 Mar 3;85(5):377-84. doi: 10.1093/jnci/85.5.377.

Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.神经生长因子受体（TRK-A）在人神经母细胞瘤细胞系中的表达及功能

Prog Clin Biol Res. 1994;385:169-75.

[Biological markers for the prognosis of neuroblastoma: proposal of a method of analysis].[神经母细胞瘤预后的生物标志物：一种分析方法的建议]

Bull Cancer. 1998 Mar;85(3):262-6.

引用本文的文献

Diagnostic technologies for neuroblastoma.神经母细胞瘤的诊断技术

Lab Chip. 2025 Jul 14. doi: 10.1039/d4lc00005f.

Horner syndrome in a pediatric patient.一名儿科患者的霍纳综合征

Pediatr Investig. 2025 Feb 14;9(2):167-171. doi: 10.1002/ped4.12470. eCollection 2025 Jun.

Revisiting the role of radiotherapy in the treatment of neuroblastoma 4S: 30 years of institutional experience and systematic review.重新审视放射治疗在4S期神经母细胞瘤治疗中的作用：30年的机构经验及系统评价

Clin Transl Radiat Oncol. 2024 May 5;47:100791. doi: 10.1016/j.ctro.2024.100791. eCollection 2024 Jul.

Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.基于 INSS 分期 4 期和 4S 神经母细胞瘤之间差异 DNA 甲基化增强子的整合分析，利用机器学习确定神经母细胞瘤的诊断和预后标志物。

J Cancer Res Clin Oncol. 2024 Mar 21;150(3):148. doi: 10.1007/s00432-024-05650-4.

Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors.恶性肿瘤中诱导分化治疗的特征与治疗前景

Front Genet. 2023 Sep 8;14:1271381. doi: 10.3389/fgene.2023.1271381. eCollection 2023.

NTRK1/TrkA Activation Overrides the G/M-Checkpoint upon Irradiation.NTRK1/TrkA激活可在辐射时克服G/M期检验点。

Cancers (Basel). 2021 Nov 30;13(23):6023. doi: 10.3390/cancers13236023.

Spontaneous regression of neuroblastoma.神经母细胞瘤的自发消退。

Cell Tissue Res. 2018 May;372(2):277-286. doi: 10.1007/s00441-017-2761-2. Epub 2018 Jan 5.

Mechanisms of neuroblastoma regression.神经母细胞瘤消退的机制。

Nat Rev Clin Oncol. 2014 Dec;11(12):704-13. doi: 10.1038/nrclinonc.2014.168. Epub 2014 Oct 21.

Preclinical models for neuroblastoma: establishing a baseline for treatment.神经母细胞瘤的临床前模型：建立治疗基准。

PLoS One. 2011 Apr 29;6(4):e19133. doi: 10.1371/journal.pone.0019133.

Recent advances in neuroblastoma.神经母细胞瘤的最新进展

N Engl J Med. 2010 Jun 10;362(23):2202-11. doi: 10.1056/NEJMra0804577.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验